Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb;28(2):177-178.
doi: 10.1007/s10157-023-02418-x. Epub 2023 Oct 17.

Development of pauci-immune necrotizing glomerulonephritis during pembrolizumab treatment

Jun Matsumoto  1 , Yosuke Saka  2 , Tomohiko Naruse  2
Affiliations

Development of pauci-immune necrotizing glomerulonephritis during pembrolizumab treatment

Jun Matsumoto et al. Clin Exp Nephrol. 2024 Feb.
No abstract available

Keywords: Immune checkpoint inhibitor; Pauci-immune necrotizing glomerulonephritis; Pembrolizumab.

PubMed Disclaimer

References

    1. Darvin P, Toor SM, Sasidharan Nair V, Elkord E. Immune checkpoint inhibitors: recent progress and potential biomarkers. Exp Mol Med. 2018;50:1–11. - DOI - PubMed
    1. Wanchoo R, Karam S, Uppal NN, Barta VS, Deray G, Devoe C, et al. Adverse renal effects of immune checkpoint inhibitors: a narrative review. Am J Nephrol. 2017;45:160–9. - DOI - PubMed
    1. Cortazar FB, Marrone KA, Troxell ML, Ralto KM, Hoenig MP, Brahmer JR, et al. Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors. Kidney Int. 2016;90:638–47. - DOI - PubMed - PMC
    1. He X, Liu F, Jin Y, Fu H, Mao J. Glomerular diseases after immune checkpoint inhibitors use: What do We know so far? Ren Fail. 2022;44:2046–55. - DOI - PubMed - PMC

MeSH terms

Substances

LinkOut - more resources